Anderson Raymond
SEC Form 4 insider trading activity
Anderson Raymond has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, Anderson Raymond is listed as Director at Monopar Therapeutics. Inside the rolling window, Anderson Raymond reported no open-market purchases and 1 open-market sale totaling $423K in MNPR.
Companies traded
Other insiders at MNPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$423K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Anderson Raymond made?
Anderson Raymond has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Anderson Raymond trade?
Anderson Raymond has filed SEC Form 4 disclosures for 1 company, including MNPR.
When was Anderson Raymond's most recent SEC Form 4 filing?
Anderson Raymond's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is Anderson Raymond's total buy and sell value in the current window?
Inside the rolling retention window, Anderson Raymond bought $0 and sold $423K based on SEC Form 4 filings.
What was Anderson Raymond's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,788 MNPR shares on 2026-08-25, worth $423K, per SEC Form 4 filings.